Valvuloplasty stands as a pivotal medical intervention dedicated to addressing valvular heart disease, a condition marked by the impairment or constriction of heart valves. In this sophisticated procedure, a specialized catheter, housing a deflated balloon, navigates through the intricate network of blood vessels until it reaches the targeted heart valve in need of correction. With precision and care, the balloon is then inflated, strategically widening the narrowed valve. This meticulous approach facilitates improved blood circulation, mitigating symptoms associated with valvular disorders and promoting overall cardiovascular health. Distinguished by its minimally invasive nature, valvuloplasty presents a compelling alternative to the conventional realm of open-heart surgery. This innovation translates to shorter recovery periods and diminished postoperative discomfort for patients undergoing the procedure. As medical advancements continue to propel the field forward, valvuloplasty emerges as a beacon of hope for individuals grappling with valvular heart disease, offering a less invasive avenue for restoring cardiac function and enhancing the quality of life.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt